In 2003, Morana Jovan-Embiricos, PhD, co-founded F2 Ventures, a biotech venture capital platform and has since served as its Managing Partner. Prior to joining F2 Ventures, Dr. Jovan was a partner at MPM Capital. Dr. Jovan currently serves on the boards of directors of Damon Runyon Cancer Center Research Foundation, TriNetX, Inc. and Cullinan Oncology. Dr. Jovan received her PhD in biophysical chemistry from the University of Cambridge and was a post-doctoral fellow at Harvard University.